Androgen deprivation therapy in men with prostate cancer: how should the side effects be monitored and treated?
about
Saudi oncology society and Saudi urology association combined clinical management guidelines for prostate cancerSex Hormones and Their Receptors Regulate Liver Energy HomeostasisCognitive changes associated with ADT: a review of the literatureThe role of androgens in metabolism, obesity, and diabetes in males and femalesCognitive impairment among prostate cancer patients: An overview of reviews.The use of dietary supplements to alleviate androgen deprivation therapy side effects during prostate cancer treatmentDevelopment of UK guidance on the management of erectile dysfunction resulting from radical radiotherapy and androgen deprivation therapy for prostate cancer.Nutrition therapy with high intensity interval training to improve prostate cancer-related fatigue in men on androgen deprivation therapy: a study protocolAndrogen deprivation therapy and fracture risk in Chinese patients with prostate carcinoma.Androgen deprivation therapy toxicity and management for men receiving radiation therapyHematological changes during androgen deprivation therapyAdvanced prostate cancer: treatment and patient-centred care.Improving the management of patients with prostate cancer receiving long-term androgen deprivation therapy.Is intermittent androgen-deprivation therapy beneficial for patients with advanced prostate cancer?When and when not to use testosterone for palliation in cancer care.An investigation of the support needs of men and partners throughout the prostate cancer journey.Positive and negative mood in men with advanced prostate cancer undergoing androgen deprivation therapy: considering the role of social support and stress.Concurrent Diabetes Mellitus may Negatively Influence Clinical Progression and Response to Androgen Deprivation Therapy in Patients with Advanced Prostate Cancer.Androgen-deprivation therapy in men with metastatic prostate cancer: less may not necessarily be moreAmerican Cancer Society prostate cancer survivorship care guidelines.Intermittent androgen deprivation therapy in patients with prostate cancer: Connecting the dots.Saudi Oncology Society and Saudi Urology Association combined clinical management guidelines for prostate cancer 2017.
P2860
Q26747782-1EC03AE5-7977-4475-8ABC-4E0B8D271FCFQ26778426-1B766897-4DD3-401A-8F39-0AAD4A0A849CQ26822767-61462AAA-EF27-439E-91DC-0238036D3901Q26824343-131FFD5A-3FB2-4C08-B361-2FE70CD669BDQ30236039-974EF2B1-4FCD-4C1B-A036-03C8CC7BB85EQ34411758-512F0B36-2ACA-48D7-BB69-9BF80F55D4BCQ35022939-61366496-1EF0-4C4C-AA75-1BDE44F0EF25Q36238990-36D2B75F-DCA7-4741-AB03-D391804E8779Q36269807-055CA52C-3281-4C28-AFD1-2CB529878105Q36530136-ED78D259-E2C4-4D81-B6B1-1D7A17B5FAC9Q37074374-D3144E8B-E9D6-44BE-8671-9FEBFBD87A81Q37999367-A7FDD466-31FC-437C-860D-8127665CCA0EQ38016531-A70B841C-BCA7-443A-9D40-C182B2160223Q38179060-B1E9E3D9-04B3-4952-B78F-CF1FF8F93046Q38186655-569DED9D-5A7C-48ED-8BCD-B1B98641A3CBQ38563258-51745243-BE15-459C-8A94-2B8E2D8E81FDQ39124003-4D983CCE-463D-481A-AC9E-8E075DC660E0Q40782810-B5047806-FDE1-475C-8240-D2249BD46AF2Q42069754-D7BAD75B-2EAE-448C-B4AC-8CDAD4521176Q48073617-A02C395C-1FD8-4B44-A0ED-B4200763E15FQ54940363-3EF08C94-D226-4330-98CD-607B26A12906Q55024078-DCDD622F-CC0C-453C-B109-6EF9C6D44569
P2860
Androgen deprivation therapy in men with prostate cancer: how should the side effects be monitored and treated?
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Androgen deprivation therapy i ...... ects be monitored and treated?
@en
Androgen deprivation therapy i ...... ects be monitored and treated?
@nl
type
label
Androgen deprivation therapy i ...... ects be monitored and treated?
@en
Androgen deprivation therapy i ...... ects be monitored and treated?
@nl
prefLabel
Androgen deprivation therapy i ...... ects be monitored and treated?
@en
Androgen deprivation therapy i ...... ects be monitored and treated?
@nl
P2860
P1476
Androgen deprivation therapy i ...... ects be monitored and treated?
@en
P2093
Jeffrey D Zajac
Mathis Grossmann
P2860
P304
P356
10.1111/J.1365-2265.2010.03939.X
P577
2011-03-01T00:00:00Z